Which pricing strategy in the pharmaceutical industry bases a drug's price primarily on measurable patient outcomes rather than production costs or competitor prices?

The pharmaceutical industry has undergone significant changes in pricing strategies over the past decade, moving from traditional cost-plus models toward more sophisticated approaches. Value-based pricing has emerged as a critical strategy as healthcare systems worldwide face mounting pressure to control costs while ensuring patient access to innovative treatments. Test your knowledge about this important trend reshaping how medications are priced and marketed to healthcare systems.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Value-based pricing (outcomes-based pricing)
Tiered pricing (differential pricing by market)
Reference pricing (external price referencing)
Cost-plus pricing (markup-based pricing)